Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04643106

Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function

A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
Female
Age
19 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.

Detailed description

In women with endometrioma who plan to undergo laparoscopic ovarian cystectomy, surgical technique can influence postoperative ovarian function because of removal of normal ovarian tissue with ovarian cyst and damage to ovarian tissue during bleeding control after stripping of endometrioma. This study is designed to compare hemostatic sealant to suturing in terms of hemostatic function, safety and preservation of ovarian function. Ovarian function of all patients will be evaluated on pre op, post op 12 weeks, post op 48 weeks by measuring AMH and ovarian volume. And Hemostatic function will be evaluated by measuring serum hemoglobin, blood loss during operation, etc.

Conditions

Interventions

TypeNameDescription
PROCEDUREHemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomyDuring laparoscopic ovarian cystectomy, bleeding will be controlled by using a hemostatic agent (EVICEL®)
PROCEDUREsuturing with barbed sutures during laparoscopic ovarian cystectomyDuring laparoscopic ovarian cystectomy, suturing of ovarian inner surface will be conducted to stop bleeding

Timeline

Start date
2021-02-25
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2020-11-24
Last updated
2023-06-26

Locations

2 sites across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04643106. Inclusion in this directory is not an endorsement.